These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3127848)

  • 1. Independence of amphetamine reward from locomotor stimulation demonstrated by conditioned place preference.
    Carr GD; Phillips AG; Fibiger HC
    Psychopharmacology (Berl); 1988; 94(2):221-6. PubMed ID: 3127848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of early handling on amphetamine-induced locomotor activation and conditioned place preference in the adult rat.
    Campbell J; Spear LP
    Psychopharmacology (Berl); 1999 Apr; 143(2):183-9. PubMed ID: 10326781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locomotor and rewarding effects of amphetamine in enriched, social, and isolate reared rats.
    Bowling SL; Bardo MT
    Pharmacol Biochem Behav; 1994 Jun; 48(2):459-64. PubMed ID: 8090815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotion and conditioned place preference produced by acute intravenous amphetamine: role of dopamine receptors and individual differences in amphetamine self-administration.
    Bardo MT; Valone JM; Bevins RA
    Psychopharmacology (Berl); 1999 Mar; 143(1):39-46. PubMed ID: 10227078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditioned locomotor activity but not conditioned place preference following intra-accumbens infusions of cocaine.
    Hemby SE; Jones GH; Justice JB; Neill DB
    Psychopharmacology (Berl); 1992; 106(3):330-6. PubMed ID: 1570378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrete quinolinic acid lesions of the rat prelimbic medial prefrontal cortex affect cocaine- and MK-801-, but not morphine- and amphetamine-induced reward and psychomotor activation as measured with the place preference conditioning paradigm.
    Tzschentke TM; Schmidt WJ
    Behav Brain Res; 1998 Dec; 97(1-2):115-27. PubMed ID: 9867237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-accumbens protein kinase C inhibitor NPC 15437 blocks amphetamine-produced conditioned place preference in rats.
    Aujla H; Beninger RJ
    Behav Brain Res; 2003 Dec; 147(1-2):41-8. PubMed ID: 14659568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat.
    Steiner MA; Lecourt H; Jenck F
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):417-32. PubMed ID: 22436395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of calcineurin inhibition and protein kinase A activation on nucleus accumbens amphetamine-produced conditioned place preference in rats.
    Gerdjikov TV; Beninger RJ
    Eur J Neurosci; 2005 Aug; 22(3):697-705. PubMed ID: 16101751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP-dependent protein kinase and reward-related learning: intra-accumbens Rp-cAMPS blocks amphetamine-produced place conditioning in rats.
    Beninger RJ; Nakonechny PL; Savina I
    Psychopharmacology (Berl); 2003 Oct; 170(1):23-32. PubMed ID: 12768275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restrained rats learn amphetamine-conditioned locomotion, but not place preference.
    Swerdlow NR; Koob GF
    Psychopharmacology (Berl); 1984; 84(2):163-6. PubMed ID: 6438675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female and male rats in late adolescence differ from adults in amphetamine-induced locomotor activity, but not in conditioned place preference for amphetamine.
    Mathews IZ; McCormick CM
    Behav Pharmacol; 2007 Nov; 18(7):641-50. PubMed ID: 17912048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional heterogeneity of the rat medial prefrontal cortex: effects of discrete subarea-specific lesions on drug-induced conditioned place preference and behavioural sensitization.
    Tzschentke TM; Schmidt WJ
    Eur J Neurosci; 1999 Nov; 11(11):4099-109. PubMed ID: 10583498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Wnt signalling dose-dependently impairs the acquisition and expression of amphetamine-induced conditioned place preference.
    Islam F; Xu K; Beninger RJ
    Behav Brain Res; 2017 May; 326():217-225. PubMed ID: 28284949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats.
    Meyer A; Mayerhofer A; Kovar KA; Schmidt WJ
    Neurosci Lett; 2002 Sep; 330(3):280-4. PubMed ID: 12270646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
    Tan SE
    Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social reward-conditioned place preference: a model revealing an interaction between cocaine and social context rewards in rats.
    Thiel KJ; Okun AC; Neisewander JL
    Drug Alcohol Depend; 2008 Aug; 96(3):202-12. PubMed ID: 18430522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of diazepam on conditioned place preference induced by morphine or amphetamine in the rat.
    Leri F; Franklin KB
    Psychopharmacology (Berl); 2000 Jul; 150(4):351-60. PubMed ID: 10958076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference.
    Layer RT; Uretsky NJ; Wallace LJ
    Brain Res; 1993 Jul; 617(2):267-73. PubMed ID: 8402155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amygdala mediates memory consolidation for an amphetamine conditioned place preference.
    Hsu EH; Schroeder JP; Packard MG
    Behav Brain Res; 2002 Feb; 129(1-2):93-100. PubMed ID: 11809499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.